Commentary

It has been estimated that more than a million occlusal splints are constructed in the USA each year.1 There is limited evidence for their effectiveness in the management of temporomandibular disorders (TMD)2 and this review considers their effectiveness in the treatment of sleep bruxism.

Sleep bruxing is characterised by teeth grinding or clenching during sleep and is usually accompanied by tooth contact sounds.3 Although tooth surface loss, TMD and headaches are potential consequences of bruxing, it can be misleading to consider them as being signs and symptoms of the underlying disorder.

Only five studies met the rigorous Cochrane Collaboration criteria for inclusion in this review. Outcome measures for only three of these studies were obtained by polysomnography, which is potentially sensitive enough to detect bruxing. The outcome measure for one other study was reduction in temporomandibular joint sounds and for another was tooth surface loss. Use of secondary signs and symptoms that are presumed to be associated with bruxism is not suitable for the purpose of the review since the nature of the association is unknown.

The inclusion of those studies, however, did not affect the conclusion of the review: evidence is insufficient to affirm that the occlusal splint is effective in treating bruxism. The reviewers explain that this can be attributed mainly to the inadequate methodology of previous studies. Attention is drawn particularly to the need for adequate sample size for statistical power. Lack of clarity regarding diagnostic criteria and information about the natural course of the disorder has also hampered investigation. In that respect, the authors' conclusion that standardisation of the outcomes of treatment should be established is well made. Bruxing episodes per hour of sleep and episodes of mandibular movement with tooth contact sounds have been used previously and should form the basis of future assessments.